Use of novel antithrombotic agents for COVID‐19: Systematic summary of ongoing randomized controlled trials

Azita H. Talasaz; Parham Sadeghipour; Maryam Aghakouchakzadeh; Hessam Kakavand; Hamid Ariannejad; Jean M. Connors; Beverley J. Hunt; Jeffrey S. Berger; Benjamín Van Tassell; Saskia Middeldorp; Gregory Piazza; Jeffrey I. Weitz; Mary Cushman; Professor Gregory Lip; Samuel Z. Goldhaber; Behnood Bikdeli

doi:10.1111/jth.15533

Preprint2021

Antithrombotic Therapy in COVID-19: Systematic Summary of Ongoing or Completed Randomized Trials

Azita H. Talasaz, Parham Sadeghipour, Hessam Kakavand, Maryam Aghakouchakzadeh, Elaheh Kordzadeh-Kermani, Benjamín Van Tassell, Azin Gheymati, Hamid Ariannejad, Seyed Hossein Hosseini, Sepehr Jamalkhani, Michelle Sholzberg, Manuel Monréal, David Jiménez, Gregory Piazza, Sahil A. Parikh, Ajay J. Kirtane, John W. Eikelboom, Jean M. Connors, Beverley J. Hunt, Stavros Konstantinides, Mary Cushman, Jeffrey I. Weitz, Gregg W. Stone, Harlan M. Krumholz, Professor Gregory Lip, Samuel Z. Goldhaber, Behnood Bikdeli

Article2021

Recent Randomized Trials of Antithrombotic Therapy for Patients With COVID-19

Azita H. Talasaz, Parham Sadeghipour, Hessam Kakavand, Maryam Aghakouchakzadeh, Elaheh Kordzadeh-Kermani, Benjamín Van Tassell, Azin Gheymati, Hamid Ariannejad, Seyed Hossein Hosseini, Sepehr Jamalkhani, Michelle Sholzberg, Manuel Monréal, David Jiménez, Gregory Piazza, Sahil A. Parikh, Ajay J. Kirtane, John W. Eikelboom, Jean M. Connors, Beverley J. Hunt, Stavros Konstantinides, Mary Cushman, Jeffrey I. Weitz, Gregg W. Stone, Harlan M. Krumholz, ,

Article2023

Spin in randomized controlled trials of pharmacology in COVID-19: A systematic review

Yun-Kyoung Oh, Youn-Joo Jung, Sujata Purja, Minji Kim, Dong Keon Yon, Seung Won Lee, Kyuyeon Cho, Ai Koyanagi, Zhaoli Dai, Lee Smith, Jae Il Shin, Eun Young Kim

Preprint2021

Lipid-Modulating Agents for Prevention or Treatment of COVID-19 in Randomized Trials

Azita H. Talasaz, Parham Sadeghipour, Maryam Aghakouchakzadeh, Isaac Dreyfus, Hessam Kakavand, Hamid Ariannejad, Aakriti Gupta, Mahesh V. Madhavan, Benjamín W. Van Tassell, David González Jiménez, Manuel Monréal, Muthiah Vaduganathan, John Fanikos, Dave L. Dixon, Gregory Piazza, Sahil A. Parikh, Deepak L. Bhatt, Professor Gregory Lip, Gregg W. Stone, Harlan M. Krumholz, Peter Libby, Samuel Z. Goldhaber, Behnood Bikdeli

Article2021

COVID-19: A Catalyst for Transforming Randomized Trials

Jennifer Lee, Jerri C. Price, William M. Jackson, Robert A. Whittington, John P A Ioannidis

Use of novel antithrombotic agents for COVID‐19: Systematic summary of ongoing randomized controlled trials

Discussion(0)

Related publications

Antithrombotic Therapy in COVID-19: Systematic Summary of Ongoing or Completed Randomized Trials

Recent Randomized Trials of Antithrombotic Therapy for Patients With COVID-19

Spin in randomized controlled trials of pharmacology in COVID-19: A systematic review

Lipid-Modulating Agents for Prevention or Treatment of COVID-19 in Randomized Trials

COVID-19: A Catalyst for Transforming Randomized Trials